Clinical inquiries. Angiotensin blockade for diabetes: monitor microalbuminuria?
Muench
John
J
Department of Family Medicine, Oregon Health and Science University, Portland, USA.
Blenning
Carol
C
Judkins
Dolores Zegar
DZ
Vincent
Chris
C
D000419:Albuminuria / Q000188:drug therapy / Q000517:prevention & control*; D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003928:Diabetic Nephropathies / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D019317:Evidence-Based Medicine; D005194:Family Practice; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D008991:Monitoring, Physiologic / Q000592:standards / Q000639:trends; D044139:Receptor, Angiotensin, Type 2 / Q000008:administration & dosage; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016482:Urinalysis
D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D044139:Receptor, Angiotensin, Type 2